相关实验视频

Updated: Jul 5, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

通过HDAC5/Smad3信号通路,GRK5促进了纤维化

Huiling Xiang¹, Jing Huang¹, Anni Song¹

¹Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

|January 11, 2024

概括

在纤维化中,G蛋白结合受体激酶5 (GRK5) 过度表达. 抑制GRK5可能为治疗慢性病和预防末期病提供新的策略.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
分子生物学分子生物学
生物化学生物化学

背景情况:

纤维化是慢性病 (CKD) 的标志,导致末期病 (ESRD) 并影响人口老龄化.
在纤维化病原发生过程中,G蛋白结合受体激酶 (GRKs),特别是GRK5的作用尚不清楚.
GRK5是一种氨酸/氨酸激酶,参与调节G蛋白合受体 (GPCR) 信号传输,已知在心脏病和癌症中的作用.

研究的目的:

研究GRK5在纤维化发展中的作用.
阐明GRK5影响纤维化进展的分子机制.

主要方法:

在纤维化模型中分析GRK5表达.
研究GRK5核转位及其与基因素脱乙酶 (HDACs) 的相互作用.
对GRK5/HDAC5/Smad3信号通路的检查.

主要成果:

发现GRK5在纤维化中显著过度表达.
GRK5转移到核中,并调节素脱乙酶5 (HDAC5) 的表达.
GRK5在HDAC5/Smad3通路上游起作用,影响肌细胞增强因子2A (MEF2A) 和Smad7转录,最终激活Smad3.

结论:

GRK5在纤维化病原发生过程中起着至关重要的作用.
GRK5被确定为缓解纤维化的潜在治疗标.
抑制GRK5活性是一种有希望的策略,可以减缓慢性病的进展.

关键词:

与G蛋白结合的受体激酶5 基因组脱乙酶 5 基因组脱乙酶 5 脏纤维化脏纤维化

更多相关视频

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...